Global Pharmaceutical Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CAMPBELL, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) -- VIVUS LLC today announced the promotion of Santosh T. Varghese, MD, to President VIVUS Global...

Dr. Discordia brings over 30 years of pharmaceutical industry experience to CaaMTech ISSAQUAH, Wash. - February 17, 2022 - (Newswire.com) CaaMTech, Inc. announced today that the company has appointed Robert (Bob) Discordia, Ph.D., as its Chief Scientific Officer (CSO). Dr....

Biopharma and life sciences organizations strengthen their leadership teams and board with these Movers & Shakers.

Published: Jun 03, 2021 By Alex Keown 180 Life Sciences -- Russell T. Ray and Teresa DeLuca were appointed to the board of directors of 180 Life Sciences. Ray was formerly Managing Director and co-Head of Global Health Care at Credit Suisse First Boston Corporation. More recently, Ray was a Partner and Senior Advisor to HLM Venture Partners, a health care-focused venture capital firm. He currently serves on the board of directors of Merrimack Pharmaceuticals, Inc. DeLuca comes to 180 Life Sciences as both a public independent board director and former senior executive Chief Medical Of...

Published: Jun 01, 2021 Experienced technical operations and CMC leader brings scientific and strategic expertise in oncology drug development and life cycle management NEW YORK, June 1, 2021 /PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced the appointment of David C. Hanley, Ph.D., as Chief Technical Operations Officer, joining the Company's executive management team. In his new role, Dr. Hanley will oversee all early- and late-s...